Cel Sci CVM
NYSE CVM
$2.04 +0.25 (+13.97%)
As of: Sep 30, 2026 · 3:58 PM EDT

Cel Sci (CVM) Long-Term Deferred Tax (2021 - 2023)

Updated

Cel Sci's Long-Term Deferred Tax came in at $60 million for fiscal Q4 2023 (quarter ended Sep 30, 2023), up 13.4% from $52.9 million a year earlier.

Analysis

Cel Sci (CVM) Long-Term Deferred Tax (2021 - 2023) Analysis & Trends

  • Going back by fiscal year, Long-Term Deferred Tax was $52.9 million in FY2022 (+20.0%) and $44.1 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Cel Sci 3.22 Mn -22.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 60.00 Mn
Sep 30, 2022 52.90 Mn
Sep 30, 2021 44.10 Mn
API Access

Cel Sci Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=CVM&period=max&api_key=YOUR_API_KEY